DGX

Quest Diagnostics

$187.61

+2.29 (+1.24%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$197.25
(+5.14%)
Strong Buy: 1
Buy: 7
Hold: 10
Sell: 0
Strong Sell: 0
Description:
Quest Diagnostics Incorporated (DGX) is a leading American clinical laboratory and a formidable presence in the healthcare industry, consistently ranked among the Fortune 500 companies. Operating across the United States, Puerto Rico, Mexico, and Brazil, the company offers a comprehensive suite of diagnostic testing services crucial for healthcare providers and individual health management. Quest's strategic alliances with hospitals and clinics worldwide enhance its service delivery and accessibility, while its dedication to innovation keeps it at the forefront of patient care advancements and diagnostic solutions.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
500 PLAZA DRIVE, SECAUCUS, NJ, UNITED STATES, 07094
Fiscal year end:
December
Market capitalization:
$20.7 Billion
EBITDA:
$2.14 Billion
PERatio:
21.73
EPS:
8.53
Dividend per share:
$3.15
Dividend yield:
1.69%
Beta:
0.623

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+216%
How much will you get:
$3,164
Prices dates:
30-10-2015: $55.62 and 31-10-2025: $175.95